·ETF Intelligence

ETF · Exchange Traded Fund

IBB

iShares Biotechnology ETF

$170.66

↑0.17(0.10%)

Total Assets

$7.9B

Expense Ratio

—

Holdings

Top 20 shown

What is this ETF?

Tracks biotech companies including drug developers and genomics firms. High volatility, high potential, concentrated in clinical-stage drug companies.

What themes are you invested in?

Through IBB, you have exposure to these market themes.

Pharmaceuticals & Biotech

LLY 8.2%REGN 7.9%VRTX 7.4%AMGN 6.8%GILD 6.2%MRNA 3.8%ILMN 3.4%EXAS 2.8%INCY 2.4%CRSP 1.3%

50.2%

of ETF

Gene Editing & Genomics

VRTX 7.4%EXAS 2.8%CRSP 1.3%

11.5%

of ETF

Weight Loss Drugs

LLY 8.2%

8.2%

of ETF

Companies we cover in this ETF

Click any to read the full plain-English research.

LLY

8.2% of ETF

REGN

7.9% of ETF

VRTX

7.4% of ETF

AMGN

6.8% of ETF

GILD

6.2% of ETF

MRNA

3.8% of ETF

ILMN

3.4% of ETF

EXAS

2.8% of ETF

INCY

2.4% of ETF

CRSP

1.3% of ETF

Top 20 holdings

LLYEli Lilly

8.2%

REGNRegeneron

7.9%

VRTXVertex Pharmaceuticals

7.4%

AMGNAmgen

6.8%

GILDGilead Sciences

6.2%

BIIBBiogen

4.5%

MRNAModerna

3.8%

ILMNIllumina

3.4%

ALNYAlnylam Pharma

3.1%

EXASExact Sciences

2.8%

SGENSeagen

2.6%

INCYIncyte

2.4%

BMRNBioMarin Pharma

2.2%

IONSIonis Pharmaceuticals

2.0%

NBIXNeurocrine Biosciences

1.9%

FATEFate Therapeutics

1.7%

ACADACADIA Pharma

1.6%

ARWRArrowhead Pharma

1.4%

CRSPCRISPR Therapeutics

1.3%

PTGXProtagonist Therapeutics

1.1%

Sector breakdown

Healthcare

100%